Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2000
03/30/2000WO2000016791A1 Myrtle extract, preparation method and use
03/30/2000WO2000016779A1 Antiviral combinations comprising lamivudine and abacavir
03/30/2000WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/30/2000WO2000016764A2 Pharmaceutical compositions comprising derivatives of sulphur acids
03/30/2000WO2000016757A2 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
03/30/2000WO2000016756A2 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors
03/30/2000WO2000016755A2 Antiviral combinations of lamivudine and adefovir
03/30/2000WO2000016746A2 Immunogenic liposome compositions
03/30/2000WO2000016745A2 Micronised pharmaceutical compositions
03/30/2000WO2000016732A2 ANTI-MICROBIAL-ADHESION FRACTION DERIVED FROM $i(VACCINIUM)
03/30/2000WO2000016632A2 Environmentally benign crop protection agents
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000016624A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof
03/30/2000WO2000016623A1 Antifouling agents
03/30/2000WO2000004016A3 Polymorph of ritonavir
03/30/2000WO2000002913B1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
03/30/2000WO2000000214A3 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
03/30/2000WO1999067393A3 Aav scleroprotein, production and use thereof
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
03/30/2000WO1999061608A3 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
03/30/2000DE19843222A1 Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen Use of organophosphorus compounds for therapeutic and prophylactic treatment of infections
03/30/2000CA2354037A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000CA2345242A1 Anti-microbial-adhesion fraction derived from vaccinium
03/30/2000CA2345233A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof
03/30/2000CA2345232A1 Environmentally benign crop protection agents
03/30/2000CA2345111A1 Antifouling agents
03/30/2000CA2344867A1 Use of aminoalkylphosphonic acid derivatives for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344172A1 Antiviral combinations
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343090A1 Retroviral particles protected against complement mediated destruction
03/30/2000CA2342783A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2339866A1 Recombinant celo virus and celo virus dna
03/29/2000EP0989127A1 An antifungal lactone compound
03/29/2000EP0989119A1 Process and intermediates for preparing trovafloxacin acid salts
03/29/2000EP0988862A2 Formulation for use in immunisation
03/29/2000EP0988861A1 Stabilized protein compositions
03/29/2000EP0988548A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988374A1 Hydrophilic composition containing protease produced by vibrio
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988314A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
03/29/2000EP0988310A1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
03/29/2000EP0988309A1 C-4''-substituted macrolide derivatives
03/29/2000EP0988308A1 9-oxime erythromycin derivatives
03/29/2000EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
03/29/2000EP0988054A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
03/29/2000EP0988051A1 Lyme combination compositions and uses
03/29/2000EP0988049A2 Pharmaceutical composition for treating hepatitis b virus (hbv) infection
03/29/2000EP0988048A1 Ligand/lytic peptide compositions and methods of use
03/29/2000EP0988042A1 A combination therapy for hiv infections
03/29/2000EP0987957A1 Method for administering viable microorganism composition for poultry
03/29/2000EP0987942A1 Pharmaceutical composition and methods for using it
03/29/2000EP0778731B1 Ionene polymers containing biologically-active anions
03/29/2000CN1249002A Component of bromelain
03/29/2000CN1248914A Pharmaceutical composition
03/29/2000CN1248911A Opthalmic non-irritating iodine medicament and method
03/29/2000CN1248581A Separation for cephalosporin isomer
03/29/2000CN1248580A Process for preparing monacid salt of tonorfloxacin
03/29/2000CN1248464A Medicine for anti-tubercle bacillus and preparation process thereof
03/29/2000CN1248444A Traditional Chinese medicinal preparation for treating pulmonary tuberculosis
03/29/2000CN1050843C Separation of cephalosporin isomers
03/28/2000US6043365 Reacting biaryl or carbocyclic or heterocyclic isopropyl nitrile derivative with a lower alkyl ester of formic acid, condensing the intermediate formed with an aminoalkyl ester to obtain intermediate, cyclizing and condensing
03/28/2000US6043352 Increased hybridization binding affinity and nuclease resistance
03/28/2000US6043347 Compositions and methods for treating viral infections
03/28/2000US6043283 Administering tyramine compound to patient to inhibit injury, destruction or death of neurons
03/28/2000US6043278 Perfluoralkyl substituted metallo-beta-lactamase inhibitors
03/28/2000US6043276 Compounds obtained from salvia species having antiviral activity
03/28/2000US6043271 Method for the preparation of (±)-calanolide A and intermediates thereof
03/28/2000US6043266 Microbiocides treating gram-positive bacteria infections and persons with aids
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043248 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
03/28/2000US6043243 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
03/28/2000US6043242 Imidazopyridazines
03/28/2000US6043238 2-Aminobenzazapine derivatives
03/28/2000US6043226 3,6-ketal and enol ether macrolide antibiotics
03/28/2000US6043220 Threonine-containing protegrins
03/28/2000US6043217 Antibacterial activity against methicillin-resistant staphylococcus aureus (mrsa).
03/28/2000US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides
03/28/2000US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions
03/28/2000US6043071 GlmU
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042838 immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
03/28/2000US6042837 Administering bifunctional crosslinker comprising staphylococcal enterotoxin a to living body having target cell expressing mhc class ii antigen to direct cytotoxic t cells to lyse target cell
03/28/2000US6042836 HIV envelope polypeptides
03/28/2000US6042835 Prototype FelV isolates for use in disease models and vaccines
03/28/2000US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
03/28/2000US6042831 Epitopes of the hiv virus gp160 protein, is immunologically homologous to epitopes of the protein family of the human major histocompatiblity complex, used for diagnosis and immunization
03/28/2000US6042830 Viral agent associated with mystery swine disease
03/28/2000US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon
1 ... 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 ... 1798